HCMT
BLPH

Highland Capital Management (Texas)’s Bellerophon Therapeutics, Inc. BLPH Stock Holding History

Highland Capital Management (Texas)’s Portfolio BLPH Stock Details BLPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		– Sell
-9,260
Closed -$1.1M – 337
2015
Q2 		$1.1M Sell
9,260
-1,552
-14% -$211K 0.02% 212
2015
Q1 		$1.49M Buy
+10,812
New +$1.68M 0.03% 185

Other funds holding BLPH

NMVA
New Mountain Vantage Advisers New York $4.33B AUM 35.3% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BG
BlackRock Group London, United Kingdom $210B AUM 15.5% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Highland Capital Management (Texas)'s BLPH Position: Q3 2015 in Review

Highland Capital Management (Texas) sold out of Bellerophon Therapeutics, Inc. (BLPH) in Q3 2015, closing a stake of 9,260 shares — an estimated $1.1M sold.

Highland Capital Management (Texas) first reported a position in BLPH in Q1 2015 and held it in 2 quarters. The position peaked at $1.49M in Q1 2015. 15 funds tracked by Wall St. Rank hold BLPH as of Q3 2015.

  • Highland Capital Management (Texas) reported no remaining Bellerophon Therapeutics, Inc. position as of Q3 2015 after selling out during the quarter.
  • Highland Capital Management (Texas) sold 9,260 Bellerophon Therapeutics, Inc. shares in Q3 2015, an estimated $1.1M.
  • Highland Capital Management (Texas) first reported a position in Bellerophon Therapeutics, Inc. in Q1 2015 and held it in 2 quarters.
  • Highland Capital Management (Texas)'s Bellerophon Therapeutics, Inc. position peaked at $1.49M in Q1 2015.
  • 15 funds tracked by Wall St. Rank held Bellerophon Therapeutics, Inc. as of Q3 2015.

Based on Highland Capital Management (Texas)'s 13F filing for Q3 2015, filed 16 Nov 2015.